Figure 1From: Metabolomics of human breast cancer: new approaches for tumor typing and biomarker discoveryWorkflow of samples in the METAcancer project. Tissue samples were analyzed in parallel with mass spectrometry (GC-MS and LC-MS) and nuclear magnetic resonance (NMR) spectroscopy. The metabolic profiles were linked to the analysis of mRNA markers and protein markers. DASL, cDNA-mediated annealing, selection, extension, and ligation assay; FFPE, formalin-fixed, paraffin-embedded; RT- PCR, reverse transcriptase PCR; TMA, tissue microarray.Back to article page